(19) Liraglutide was found to improve bone mineral density and mitigate the detrimental effects of glucocorticoids on bone metabolism
doi: 10.1210/jc.2008-0519 40 MeltzerLJMontgomery-DownsHEInsanaSPWalshCM
Key details Compounded GLP-1s Semaglutide injections Semaglutide microdoses Tirzepatide injections Tirzepatide microdoses Semaglutide oral tablets, drops Tirzepatide oral tablets, drops Branded GLP-1s Ozempic Mounjaro Wegovy Zepbound Microdose options require a phone consult to sign up
The battle of probiotics and their derivatives against biofilms
Results The interaction test yielded no significant differences between the effects of the four daily oral maintenance dosages of L-carnitine (i.e., 2 g, 3 g, 4 g, and 6 g) on all-cause mortality (risk ratio [RR] = 0.77, 95% CI [0.57-1.03], P = 0.08) with a statistically insignificant trend favoring the 3 g dose (RR = 0.48) over the lower 2 g dose (RR = 0.62), which was favored over the higher 4 g and 6 g doses (RR = 0.78, 0.78)
Important safety information includes a boxed warning for risk of thyroid C-cell tumors, with contraindications in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
